This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
McNeil Recalls Children's, Infants' Tylenol, Motrin, Benadryl, Zyrtec
Generic Versions of Products Not Affected, Says FDA
By News Staff
A complete list of affected products is included in McNeil's news release.
The company said the products were being recalled because of manufacturing deficiencies that could affect quality, purity or potency. In a May 1 news release, FDA officials said that some of the recalled products may contain higher concentrations of active ingredients than specified, while others contain inactive ingredients that may not meet internal testing requirements. Other products may contain foreign particles.
Generic versions of the products -- acetaminophen (Tylenol), ibuprofen (Motrin), cetirizine (Zyrtec) and diphenhydramine (Benadryl) -- are not affected by the recall and are considered safe to use, the FDA said.
The agency said the potential for serious health problems with use of the recalled products is remote, but FDA officials advised parents and caregivers to not administer the medications to their children as a precaution.
Adverse reactions or quality problems experienced with use of the products can be reported to the FDA's MedWatch program.
Consumers can contact McNeil at (888) 222-6036 or online. The manufacturer is offering consumers with affected products refunds or coupons to use with replacement bottles.
In January, McNeil recalled more than 500 lots of OTC products -- including Benadryl, Rolaids, multiple formulations of both Motrin and Children's Motrin and numerous formulations of Tylenol and Children's Tylenol -- because of chemical contamination.
That recall came on the heels of a September 2009 action, in which the manufacturer recalled more than 50 lots of its liquid children's and infants' Tylenol products because of potential bacterial contamination.
McNeil Recalling Hundreds of Lots of Contaminated OTC Medications
FDA Criticizes Manufacturer for Handling of Investigation
(1/18/2010)
McNeil Recalls Children's, Infants' Tylenol Products
Bacterial Contamination Concerns Spur Action
(9/24/2009)
Additional Resources
FDA News Release: "FDA Provides Consumer Advice Following Recall of Products for Infants and Children"
(May 1, 2010)
McNeil Product Recall Information
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Study: PPI Does Not Routinely Improve Asthma Control
Recalled Oral Contraceptives Pose Pregnancy Risk
CDC to Fund 2D Vaccine Barcoding Pilot
2012 Immunization Schedules Reflect Multiple Changes
Study: Cognitive Decline Detected in Middle-aged Adults
CDC Toolkit Can Help Clinicians Fight Norovirus Infection
Patient-Centered Care Linked to Lower Mortality
Study: Inappropriate Cancer Screenings Continue
Novartis Manufacturing Plant Closes After Drug Mix-ups
FDA Announces Classwide REMS for TIRF Medications
New Infants' Acetaminophen Products Hit Store Shelves
Avoid Environmental Factors Linked to Breast Cancer
Risk for Thrombosis Prompts REMS for Rivaroxaban
Common Drugs Implicated in Most Emergency Hospitalizations
CDC Launches Campaign for Child Medication Safety
HHS Blocks Expanded OTC Access to Plan B
Push Is On to Vaccinate Pregnant, Postpartum Women
FDA Committee Votes to Broaden PCV13 Indication
AAFP Foundation Program Aims to Fight Chronic Disease
NIAAA Alcohol Screening Guide Targets Teens
Walgreens, AAFP Launch Flu Vaccine Pilot in Five States
Helping Patients Quit Smoking Starts With a Question
Trilipix Efficacy in Question, Says FDA
USPSTF Addresses Skin Cancer, Obesity, Cervical Cancer Screening
AAFP Endorses ACP Guideline on ED
ACIP Recommends Expanded HPV, Hepatitis B Vaccination
Bacterial Contamination Spurs Nasal Spray Recall
CDC Renews Call for PCV13 Vaccination
USPSTF Recommends Against PSA Screening
AAFP Supports HHS' Million Hearts Initiative
FDA Phases Out Primatene Mist Inhalers
AHRQ Guides Explain Benefits, Risks of GERD Treatments
Office Champions Project Nets Smoking Cessation Gains
Multiple Lots of Oral Contraceptives Recalled
New Vaccine Review Finds Few Adverse Events
HPV Vaccination Rates Still Lag, Says CDC
Renal Injury Prompts Reclast Label Changes
High-dose Citalopram Linked to Abnormal Heart Rhythms
AHRQ Sleep Apnea Guides Review Diagnosis, Management
Board Chair Spotlights Breadth of Family Medicine Training
USPSTF Softens Stance on Bladder Cancer Screening
HHS Expands Coverage for Women's Preventive Services
Teledermatology Project Aids Underserved Patients
